| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/09/2023 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 8.3k | $5.09 | $42.2k | | 05/09/2023 |
| 05/10/2022 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (Right to Buy) | 8.3k | $2.92 | $24.2k | | 05/10/2022 |
| 05/12/2021 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (right to buy) | 8.3k | $10.34 | $85.8k | | 05/12/2021 |
| 09/29/2020 | Larimar Therapeutics, Inc. | ZFGN | Grant | Stock Option (right to buy) | 16.6k | $11.90 | $197.5k | | 09/29/2020 |
| 06/08/2018 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 12.7k | $2.50 | $31.8k | | 06/08/2018 |
| 08/02/2017 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 13.3k | $1.30 | $17.3k | | 08/02/2017 |
| 02/10/2016 | AveXis, Inc. | AVXS | Grant | Stock Option (Right to Buy) | 18.1k | $20.00 | $362.2k | | 02/10/2016 |
| 02/10/2016 | AveXis, Inc. | AVXS | Grant | Stock Option (Right to Buy) | 8.4k | $20.00 | $167.7k | | 02/10/2016 |
| 09/11/2015 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to Buy) | 7.6k | $0.00 | $0 | | 09/11/2015 |
| 07/16/2015 | ALPINE IMMUNE SCIENCES, INC. | NVLS | Grant | Stock Option (Right to Buy) | 11.5k | $0.00 | $0 | | 07/16/2015 |
| 06/21/2011 | ALLOS THERAPEUTICS INC | ALTH | Grant | Stock Options (Right to Buy) | 20k | $2.06 | $41.2k | | 06/21/2011 |
| 06/07/2011 | INTERMUNE INC | ITMN | Other (acquisition) | Common Stock, par value $0.001 per share | 18.7k | $0.00 | $0 | | 06/07/2011 |
| 06/07/2011 | INTERMUNE INC | ITMN | Other (disposition) | Common Stock, par value $0.001 per share | 4.5M | $0.00 | $0 | See footnote | 06/07/2011 |
| 05/11/2011 | INTERMUNE INC | ITMN | Other (disposition) | Common Stock, par value $0.001 per share | 5M | $0.00 | $0 | See footnote | 05/11/2011 |
| 05/11/2011 | INTERMUNE INC | ITMN | Other (acquisition) | Common Stock, par value $0.001 per share | 21k | $0.00 | $0 | | 05/11/2011 |
| 04/01/2011 | Talon Therapeutics, Inc. | TLON | Grant | Stock Option (right to buy) | 35k | $0.77 | $27k | | 04/01/2011 |
| 09/10/2010 | Talon Therapeutics, Inc. | TLON | Grant | Series A-1 Convertible Preferred Stock, $0.001 Par Value | 11.3k | $0.00 | $0 | See footnotes | 09/10/2010 |
| 05/10/2010 | INTERMUNE INC | ITMN | Grant | Non-Qualified Stock Option (Right to Buy) | 12k | $10.37 | $124.4k | | 05/10/2010 |
| 01/26/2010 | INTERMUNE INC | ITMN | Exercise | Non-Qualified Stock Option (right to buy) | 10k | $4.50 | $45k | | 01/26/2010 |
| 01/26/2010 | INTERMUNE INC | ITMN | Exercise | Non-Qualified Stock Option (right to buy) | 30k | $4.50 | $135k | | 01/26/2010 |
| 01/26/2010 | INTERMUNE INC | ITMN | Purchase | Common Stock, par value $0.001 per share ("Common Stock") | 2.1M | $14.10 | $30M | See footnotes | 01/26/2010 |